Thus, dysregulation of RAAS in COVID‐19 patients’ vasculature system may trigger a cascade of incidents associated with enhanced coagulopathy which includes endothelial dysfunction, oxidative stress damage, and activation of von Willebrand factor.214. Here, VWF is linked to COVID-19.